Clinical Trials Browser

Approved for marketing × trifluridine tipiracil drug combination × Clear all

NCT02286492 2024-09-05

Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer

Approved for marketing

Gastrointestinal

Colorectal Cancer Metastatic